Solstice Achieves 400M TVL Milestone as NYSEListed Bullish Joins Institutional Allocator Network
Private Payrolls Rise 109000 in April Surpassing Expectations ADP Report
Brainbees Solutions Narrows Q4 Loss as Firstcry Parent Reports 12 Revenue Growth
Indias Five Listed REITs Distribute Over Rs 8900 Crore in FY26
AI Demand Drives Supply Constraints for Lasers Fiber Optics and Optical Components
Morgan Stanley Adjusts Palo Alto Networks Price Target Amid Evolving Cybersecurity Demand Trends
Omega Healthcare Investors Inc OHI Q1 2026 Earnings Solid EPS Beat Fails to Lift Stock
Western Midstream Partners Q1 2026 Earnings EPS Beats Estimates by 1391 Stock Rises
CINT Q1 2026 Earnings EPS Misses Estimates Stock Rises on Optimism
Ameren Corporation AEE Q1 2026 Earnings EPS Surges Past Expectations as Utility Operations Drive Steady Performance
ELS Q1 2026 Earnings Modest EPS Beat and Steady Market Response
Versus Systems Inc Q4 2025 Earnings Continued Losses Amid Restructuring Efforts
Axiom Intelligence Acquisition Corp AXIN Holds Steady at 1022 as SPAC Consolidation Continues
XORTX Therapeutics XRTX Gains 127 as Shares Test Key Resistance Level
Workiva Inc WK Declines 195 as Stock Tests Critical Support Level
Hawaiian Electric HE Slips 073 as Utility Sector Pressure Persists
Stem Inc STEM Slips 146 Amid Resistance Test Key Support at 96 in Focus
Cruz and Cantwells Potential College Football Legislation Raises Industry Concerns
NetScout Systems NTCT Q1 2026 Earnings EPS Surpasses Estimates Amid Margin Discipline
Climb Bio Inc CLYM Edges Higher Navigating Support and Resistance Levels
Park Aerospace Corp PKE Slides 231 as Support Level Nears
Karyopharm Therapeutics KPTI Edges Higher as Volume Picks Up Key Resistance Level Ahead
Alphabet Inc GOOG Nears Resistance as Modest Gains Signal Consolidation
Adamas Trust Inc ADAM Holds Steady Near Support in LowVolume Trading
Phathom Pharmaceuticals PHAT Slips 216 as Stock Tests Key Support Levels
Oaktree Specialty Lending Corporation OCSL Edges Higher as Support Holds Steady
Ekso Bionics EKSO Climbs 129 as Stock Tests Key Resistance Level